US$ 21.10
#tirzepatide Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Tirzepatide vs Semaglutide: 2026 Clinical
Description
It's used for type 2 diabetes & weight management support

This year, the company plans to start late-stage trials of the drug for #obesity in patients with/without Type 2 #diabetes + initiate studies evaluating it in combination with cholesterol drug #Praluent

Semaglutide belongs to a class of medications known as GLP-1 receptor agonists, which influence hormones involved in appetite regulation and metabolic signaling

Chills and temperature sensitivity can occur with semaglutide use, reflecting metabolic changes as the body adjusts to GLP-1 receptor activation
